{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:06:27Z","timestamp":1792821987336,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17CC0027852"],"award-info":[{"award-number":["NNF17CC0027852"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in the epigenetic modifier\n                    <jats:italic>TET2<\/jats:italic>\n                    are frequent in myeloid malignancies and clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of undetermined significance (CCUS). Here, we investigate associations between\n                    <jats:italic>TET2<\/jats:italic>\n                    mutations and DNA methylation in whole blood in 305 elderly twins, 15 patients with CCUS and 18 healthy controls. We find that\n                    <jats:italic>TET2<\/jats:italic>\n                    mutations are associated with DNA hypermethylation at enhancer sites in whole blood in CHIP and in both granulocytes and mononuclear cells in CCUS. These hypermethylated sites are associated with leukocyte function and immune response and ETS-related and C\/EBP-related transcription factor motifs. While the majority of\n                    <jats:italic>TET2-<\/jats:italic>\n                    associated hypermethylation sites are shared between CHIP and in AML, we find a set of AML-specific hypermethylated loci at active enhancer elements in hematopoietic stem cells. In summary, we show that\n                    <jats:italic>TET2<\/jats:italic>\n                    mutations is associated with hypermethylated enhancers involved in myeloid differentiation in both CHIP, CCUS and AML patients.\n                  <\/jats:p>","DOI":"10.1038\/s41467-021-26093-2","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T15:27:17Z","timestamp":1634570837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-7652","authenticated-orcid":false,"given":"Morten","family":"Tulstrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5268-3366","authenticated-orcid":false,"given":"Mette","family":"Soerensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob Werner","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0588-1663","authenticated-orcid":false,"given":"Linn","family":"Gillberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Needhamsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Kaastrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Helin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-5292","authenticated-orcid":false,"given":"Kaare","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-5524","authenticated-orcid":false,"given":"Joachim","family":"Weischenfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-9601","authenticated-orcid":false,"given":"Kirsten","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"26093_CR1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/leu.2011.44","volume":"25","author":"MJ Walter","year":"2011","unstructured":"Walter, M. J. et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 25, 1153\u20131158 (2011).","journal-title":"Leukemia"},{"key":"26093_CR2","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. New Engl. J. Med. 363, 2424\u20132433 (2010).","journal-title":"New Engl. J. Med."},{"key":"26093_CR3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau, F. et al. Mutation in TET2 in myeloid cancers. New Engl. J. Med. 360, 2289\u20132301 (2009).","journal-title":"New Engl. J. Med."},{"key":"26093_CR4","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3324\/haematol.2013.088740","volume":"98","author":"F Asmar","year":"2013","unstructured":"Asmar, F. et al. Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma. Haematologica 98, 1912\u20131920 (2013).","journal-title":"Haematologica"},{"key":"26093_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. New Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"New Engl. J. Med."},{"key":"26093_CR6","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. New Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"New Engl. J. Med."},{"key":"26093_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster, J. J. et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355, 842\u2013847 (2017).","journal-title":"Science"},{"key":"26093_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"17","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal, S. & Libby, P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat. Rev. Cardiol. 17, 137\u2013144 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"26093_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41588-020-0595-4","volume":"52","author":"F Izzo","year":"2020","unstructured":"Izzo, F. et al. DNA methylation disruption reshapes the hematopoietic differentiation landscape. Nat. Genet. 52, 378\u2013387 (2020).","journal-title":"Nat. Genet."},{"key":"26093_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1101\/gad.276568.115","volume":"30","author":"KD Rasmussen","year":"2016","unstructured":"Rasmussen, K. D. & Helin, K. Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev. 30, 733\u2013750 (2016).","journal-title":"Genes Dev."},{"key":"26093_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrc3895","volume":"15","author":"L Yang","year":"2015","unstructured":"Yang, L., Rau, R. & Goodell, M. A. DNMT3A in haematological malignancies. Nat. Rev. Cancer 15, 152\u2013165 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"26093_CR12","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-14-0739","volume":"75","author":"J Yamazaki","year":"2015","unstructured":"Yamazaki, J. et al. TET2 mutations affect Non-CpG island DNA methylation at enhancers and transcription factor-binding sites in chronic myelomonocytic Leukemia. Cancer Res. 75, 2833\u20132843 (2015).","journal-title":"Cancer Res."},{"key":"26093_CR13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1101\/gad.260174.115","volume":"29","author":"KD Rasmussen","year":"2015","unstructured":"Rasmussen, K. D. et al. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis. Genes Dev. 29, 910\u2013922 (2015).","journal-title":"Genes Dev."},{"key":"26093_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature09586","volume":"468","author":"M Ko","year":"2010","unstructured":"Ko, M. et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468, 839\u2013843 (2010).","journal-title":"Nature"},{"key":"26093_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ng.3610","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat. Genet. 48, 1014\u20131023 (2016).","journal-title":"Nat. Genet."},{"key":"26093_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25\u201338 (2011).","journal-title":"Cancer Cell"},{"key":"26093_CR17","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","volume":"34","author":"AAZ Dawoud","year":"2020","unstructured":"Dawoud, A. A. Z., Tapper, W. J. & Cross, N. C. P. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking. Leukemia 34, 2660\u20132672 (2020).","journal-title":"Leukemia"},{"key":"26093_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"Roadmap Epigenomics Consortium.","year":"2015","unstructured":"Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317\u2013329 (2015).","journal-title":"Nature"},{"key":"26093_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1101\/gr.239277.118","volume":"29","author":"KD Rasmussen","year":"2019","unstructured":"Rasmussen, K. D. et al. TET2 binding to enhancers facilitates transcription factor recruitment in hematopoietic cells. Genome Res. 29, 564\u2013575 (2019).","journal-title":"Genome Res."},{"key":"26093_CR20","first-page":"28","volume":"13","author":"K Williams","year":"2012","unstructured":"Williams, K., Christensen, J. & Helin, K. DNA methylation: TET proteins\u2014guardians of CpG islands? Nat. Publ. Gr. 13, 28\u201335 (2012).","journal-title":"Nat. Publ. Gr."},{"key":"26093_CR21","doi-asserted-by":"crossref","unstructured":"Ando, M. et al. Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers. Nat. Commun. 10, 2188 (2019).","DOI":"10.1038\/s41467-019-10557-7"},{"key":"26093_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.molcel.2014.08.026","volume":"56","author":"GC Hon","year":"2014","unstructured":"Hon, G. C. et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol. Cell 56, 286\u2013297 (2014).","journal-title":"Mol. Cell"},{"key":"26093_CR23","unstructured":"Kaasinen, E. et al. Impact of constitutional TET2 haploinsufficiency on molecular and clinical phenotype in humans. Nat. Commun. 10, 1252 (2019)."},{"key":"26093_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jlb.63.4.405","volume":"63","author":"AF Valledor","year":"1998","unstructured":"Valledor, A. F., Borr\u00e0s, F. E., Cullell-Young, M. & Celada, A. Transcription factors that regulate monocyte\/macrophage differentiation. J. Leukoc. Biol. 63, 405\u2013417 (1998).","journal-title":"J. Leukoc. Biol."},{"key":"26093_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nature23876","volume":"549","author":"M Agathocleous","year":"2017","unstructured":"Agathocleous, M. et al. Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature 549, 476\u2013481 (2017).","journal-title":"Nature"},{"key":"26093_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino, L. et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170, 1079\u20131095 (2017).","journal-title":"Cell"},{"key":"26093_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1182\/blood.2019001793","volume":"135","author":"JW Hansen","year":"2020","unstructured":"Hansen, J. W. et al. Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality. Blood 135, 261\u2013268 (2020).","journal-title":"Blood"},{"key":"26093_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1375\/twin.10.2.255","volume":"10","author":"M McGue","year":"2007","unstructured":"McGue, M. & Christensen, K. Social activity and healthy aging: a study of aging Danish twins. Twin Res. Hum. Genet. 10, 255\u2013265 (2007).","journal-title":"Twin Res. Hum. Genet."},{"key":"26093_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595 (2010).","journal-title":"Bioinformatics"},{"key":"26093_CR30","unstructured":"Garrison, E. & Marth, G. Haplotype-based variant detection from short-read sequencing. Preprint at https:\/\/arxiv.org\/abs\/1207.3907 [q-bio.GN] (2012)."},{"key":"26093_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkw550","volume":"44","author":"Z Lai","year":"2016","unstructured":"Lai, Z. et al. VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research. Nucleic Acids Res. 44, 1\u201311 (2016).","journal-title":"Nucleic Acids Res."},{"key":"26093_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma, D. P. et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126, 9\u201316 (2015).","journal-title":"Blood"},{"key":"26093_CR33","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/bioinformatics\/btu566","volume":"30","author":"M Van Iterson","year":"2014","unstructured":"Van Iterson, M. et al. MethylAid: visual and interactive quality control of large Illumina 450k datasets. Bioinformatics 30, 3435\u20133437 (2014).","journal-title":"Bioinformatics"},{"key":"26093_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen, Y. A. et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics 8, 203\u2013209 (2013).","journal-title":"Epigenetics"},{"key":"26093_CR35","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363\u20131369 (2014).","journal-title":"Bioinformatics"},{"key":"26093_CR36","doi-asserted-by":"crossref","unstructured":"Fortin, J. et al. Functional normalization of 450k methylation array data improves replication in large cancer studies. Genome Biol. 15, 503 (2014).","DOI":"10.1186\/s13059-014-0503-2"},{"key":"26093_CR37","doi-asserted-by":"crossref","unstructured":"Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinform. 13, 86 (2012).","DOI":"10.1186\/1471-2105-13-86"},{"key":"26093_CR38","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou, W., Laird, P. W. & Shen, H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 45, e22 (2017).","journal-title":"Nucleic Acids Res."},{"key":"26093_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-9-r105","volume":"14","author":"J Nordlund","year":"2013","unstructured":"Nordlund, J. et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 14, r105 (2013).","journal-title":"Genome Biol."},{"key":"26093_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-1066-1","volume":"17","author":"R Pidsley","year":"2016","unstructured":"Pidsley, R. et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 17, 1\u201317 (2016).","journal-title":"Genome Biol."},{"key":"26093_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2014","unstructured":"Morris, T. J. et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics 30, 428\u2013430 (2014).","journal-title":"Bioinformatics"},{"key":"26093_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-6-r44","volume":"13","author":"J Maksimovic","year":"2012","unstructured":"Maksimovic, J., Gordon, L. & Oshlack, A. SWAN: subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips. Genome Biol. 13, R44 (2012).","journal-title":"Genome Biol."},{"key":"26093_CR43","doi-asserted-by":"crossref","unstructured":"Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3 (2004).","DOI":"10.2202\/1544-6115.1027"},{"key":"26093_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"26093_CR45","doi-asserted-by":"crossref","unstructured":"McLeay, R. C. & Bailey, T. L. Motif enrichment analysis: a unified framework and an evaluation on ChIP data. BMC Bioinform. 11, 165 (2010).","DOI":"10.1186\/1471-2105-11-165"},{"key":"26093_CR46","doi-asserted-by":"publisher","first-page":"D252","DOI":"10.1093\/nar\/gkx1106","volume":"46","author":"IV Kulakovskiy","year":"2018","unstructured":"Kulakovskiy, I. V. et al. HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis. Nucleic Acids Res. 46, D252\u2013D259 (2018).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26093-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:15:13Z","timestamp":1669979713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-26093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["26093"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-26093-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6061"}}